Although the anti-cancer effects of DRAIC have been verified by some studies, there were still several sources of evidence that DRAIC also plays an oncogenic role in other cancers such as breast cancer (BC) and nasopharyngeal carcinoma (NPC). This evidence concerns the gene DRAIC and breast carcinoma.